PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-450

  1. 4,263 Posts.
    lightbulb Created with Sketch. 6759
    Yes agreed with what you have posted, the other unique insight we got is the parallel SAS program and the initial results that the footballers were getting under the same program, this is very rare while a Phase 2 trial is in progress. Normally it would be months and months without hearing a thing, flying in the dark until the company released some info or the clinical trial result came out. We knew about the progress to some extent before the conclusion of the Trial 2 and the respective endpoint results.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $101.6K 424.7K

Buyers (Bids)

No. Vol. Price($)
12 144266 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 18540 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.